Expectorant Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Expectorant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 207342-001 | Jul 11, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ohm Labs Inc | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 209254-001 | Jul 16, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Guardian Drug | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 209215-001 | Sep 6, 2017 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo R And D | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 078912-002 | Nov 5, 2020 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 215932-002 | Mar 15, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 215932-001 | Mar 15, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
